APA (7th ed.) Citation

Ehinger, E., Kopecky, J., Darabi, A., Visse, E., Edvardsson, C., Tomasevic, G., . . . Siesjö, P. (2023). Antisecretory factor is safe to use as add-on treatment in newly diagnosed glioblastoma. BMC Neurology, 23(1), 1. https://doi.org/10.1186/s12883-023-03119-4

Chicago Style (17th ed.) Citation

Ehinger, Erik, et al. "Antisecretory Factor Is Safe to Use as Add-on Treatment in Newly Diagnosed Glioblastoma." BMC Neurology 23, no. 1 (2023): 1. https://doi.org/10.1186/s12883-023-03119-4.

MLA (9th ed.) Citation

Ehinger, Erik, et al. "Antisecretory Factor Is Safe to Use as Add-on Treatment in Newly Diagnosed Glioblastoma." BMC Neurology, vol. 23, no. 1, 2023, p. 1, https://doi.org/10.1186/s12883-023-03119-4.